Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies
- 10 February 2021
- journal article
- review article
- Published by Wiley in Small Methods
- Vol. 5 (5), 2001207
- https://doi.org/10.1002/smtd.202001207
Abstract
Cancer‐associated pancreatic stellate cells installed in periacinar/periductal regions are master players in generating the characteristic biophysical shield found in pancreatic ductal adenocarcinoma (PDAC). Recreating this unique PDAC stromal architecture and its desmoplastic microenvironment in vitro is key to discover innovative treatments. However, this still remains highly challenging to realize. Herein, organotypic 3D microtumors that recapitulate PDAC‐stroma spatial bioarchitecture, as well as its biomolecular, metabolic, and desmoplastic signatures, are bioengineered. Such newly engineered platforms, termed stratified microenvironment spheroid models – STAMS – mimic the spatial stratification of cancer‐stromal cells, exhibit a reproducible morphology and sub‐millimeter size. In culture, 3D STAMS secrete the key molecular biomarkers found in human pancreatic cancer, namely TGF‐β, FGF‐2, IL‐1β, and MMP‐9, among others. This is accompanied by an extensive desmoplastic reaction where collagen and glycosaminoglycans (GAGs) de novo deposition is observed. These stratified models also recapitulate the resistance to various chemotherapeutics when compared to standard cancer–stroma random 3D models. Therapeutics resistance is further evidenced upon STAMS inclusion in a tumor extracellular matrix (ECM)‐mimetic hydrogel matrix, reinforcing the importance of mimicking PDAC‐stroma bioarchitectural features in vitro. The 3D STAMS technology represents a next generation of biomimetic testing platforms with improved potential for advancing high‐throughput screening and preclinical validation of innovative pancreatic cancer therapies.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia
- European Regional Development Fund
This publication has 74 references indexed in Scilit:
- 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testingBMC Cancer, 2013
- Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinomaProceedings of the National Academy of Sciences of the United States of America, 2013
- The Pancreas Cancer MicroenvironmentClinical Cancer Research, 2012
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2Cancer Research, 2011
- Perfluorocarbon emulsions as a promising technology: a review of tissue and vascular gas dynamicsJournal of Applied Physiology, 2009
- Three-dimensional context regulation of metastasisClinical & Experimental Metastasis, 2008
- Enhancer of zeste homolog 2 downregulates E‐cadherin by mediating histone H3 methylation in gastric cancer cellsCancer Science, 2008
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007
- Tumor Stroma Interactions Induce Chemoresistance in Pancreatic Ductal Carcinoma Cells Involving Increased Secretion and Paracrine Effects of Nitric Oxide and Interleukin-1βCancer Research, 2004